JP2021535175A5 - - Google Patents
Info
- Publication number
- JP2021535175A5 JP2021535175A5 JP2021512244A JP2021512244A JP2021535175A5 JP 2021535175 A5 JP2021535175 A5 JP 2021535175A5 JP 2021512244 A JP2021512244 A JP 2021512244A JP 2021512244 A JP2021512244 A JP 2021512244A JP 2021535175 A5 JP2021535175 A5 JP 2021535175A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- liver disease
- fatty liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862694848P | 2018-07-06 | 2018-07-06 | |
| US62/694,848 | 2018-07-06 | ||
| US201962809351P | 2019-02-22 | 2019-02-22 | |
| US62/809,351 | 2019-02-22 | ||
| PCT/CA2019/050915 WO2020006631A1 (en) | 2018-07-06 | 2019-07-03 | Compositions and methods for treating non-alcoholic steatohepatitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535175A JP2021535175A (ja) | 2021-12-16 |
| JP2021535175A5 true JP2021535175A5 (OSRAM) | 2022-07-12 |
| JP7399949B2 JP7399949B2 (ja) | 2023-12-18 |
Family
ID=69060680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021512244A Active JP7399949B2 (ja) | 2018-07-06 | 2019-07-03 | 非アルコール性脂肪性肝炎治療のための組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11744808B2 (OSRAM) |
| EP (2) | EP3817749A4 (OSRAM) |
| JP (1) | JP7399949B2 (OSRAM) |
| CN (1) | CN112654357B (OSRAM) |
| CA (1) | CA3105850A1 (OSRAM) |
| WO (1) | WO2020006631A1 (OSRAM) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020191503A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bromantane and derivatives thereof for treating lung disease, fatty liver disease, and kidney disorders |
| WO2020191501A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bemithyl and derivatives for treating lung disease, fatty liver disease, and kidney disorders |
| IT202100014177A1 (it) * | 2021-05-31 | 2022-12-01 | Sunnutrapharma S R L | Utilizzo della istradefillina per ridurre la fibrosi d’organo |
| CN115778957B (zh) * | 2022-11-04 | 2024-06-21 | 天津中医药大学 | 千金藤素及包含其的组合物用于预防或治疗酒精性肝病的应用 |
| CN120346213B (zh) * | 2025-05-13 | 2025-10-24 | 中国医科大学 | CD39抑制剂或A2a受体抑制剂在制备治疗非酒精性脂肪肝炎产品中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2175229C2 (ru) * | 1999-12-22 | 2001-10-27 | Научно-исследовательский институт фармакологии РАМН | Анксиолитическое средство |
| JP3885135B2 (ja) * | 2000-10-10 | 2007-02-21 | 幸彦 松田 | Ｃ型又は非ｂ非ｃ型肝炎ウイルスによる肝機能異常の改善剤 |
| RU2261709C2 (ru) * | 2003-08-15 | 2005-10-10 | Государственное учреждение Научно-исследовательский институт фармакологии Российской Академии медицинских наук | Психостимулирующее средство |
| US20100056552A1 (en) * | 2007-03-30 | 2010-03-04 | Johan Raud | Combination for use in the treatment of inflammatory disorders |
| WO2009007679A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
| WO2012157290A1 (ja) * | 2011-05-19 | 2012-11-22 | 富士化学工業株式会社 | 非アルコール性脂肪性肝炎の予防改善剤 |
| EP2818473A4 (en) * | 2012-02-20 | 2015-04-15 | Takeda Pharmaceutical | HETEROCYCLIC CONNECTION |
| RU2547141C1 (ru) * | 2014-02-28 | 2015-04-10 | Федеральное государственное бюджетное учреждение науки Институт элементоорганических соединений им. А.Н. Несмеянова Российской академии наук (ИНЭОС РАН) | Способ получения n-(4-бромфенил)-n-(2-адамантил)амина (бромантана) |
| WO2017100500A1 (en) * | 2015-12-11 | 2017-06-15 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Vesicle containing metallic nanoparticle and method for production thereof |
-
2019
- 2019-07-03 EP EP19829889.5A patent/EP3817749A4/en not_active Withdrawn
- 2019-07-03 US US17/258,402 patent/US11744808B2/en active Active
- 2019-07-03 EP EP25161422.8A patent/EP4541352A3/en active Pending
- 2019-07-03 JP JP2021512244A patent/JP7399949B2/ja active Active
- 2019-07-03 CA CA3105850A patent/CA3105850A1/en active Pending
- 2019-07-03 WO PCT/CA2019/050915 patent/WO2020006631A1/en not_active Ceased
- 2019-07-03 CN CN201980058395.1A patent/CN112654357B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021535175A5 (OSRAM) | ||
| JP2018507914A5 (OSRAM) | ||
| WO2018234568A3 (en) | HYDROXYNORKETAMINE FOR USE IN TREATING DEPRESSION | |
| JP2021530746A5 (OSRAM) | ||
| WO2018136264A9 (en) | Pyridine compounds as allosteric shp2 inhibitors | |
| EA201790124A1 (ru) | Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения | |
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| CN110114083A (zh) | 一种预防和治疗脂肪肝的方法 | |
| JP2021529829A5 (OSRAM) | ||
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| WO2015095354A3 (en) | Compositions and methods for treating fatty tissue buildup | |
| JP2015038135A5 (OSRAM) | ||
| JP2016511753A5 (OSRAM) | ||
| JP2021522247A5 (OSRAM) | ||
| WO2013183062A3 (en) | Palatable formulations of ibuprofen | |
| JP2017515854A5 (OSRAM) | ||
| JP2024028337A5 (OSRAM) | ||
| JP2015537009A5 (OSRAM) | ||
| CN111868056A (zh) | 1,2,4-噁二唑类化合物及其制备方法和医药用途 | |
| JP2015510916A5 (OSRAM) | ||
| JP2021514365A5 (OSRAM) | ||
| JP2009541409A5 (OSRAM) | ||
| JP2019510075A5 (OSRAM) | ||
| WO2019074214A3 (ko) | 황산염을 포함하는 대장 하제 조성물 | |
| JP2018505218A5 (OSRAM) |